Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
168.7(c) 165.86(c) 167.65(c) 167.95(c) 165.82 Last
1 613 881 1 394 550 1 071 126 929 948 1 285 799 Volume
+6.32% -1.68% +1.08% +0.18% -1.27% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 197 M
EBIT 2014 1 081 M
Net income 2014 709 M
Finance 2014 1 770 M
Yield 2014 -
Sales 2015 2 684 M
EBIT 2015 1 327 M
Net income 2015 931 M
Finance 2015 2 912 M
Yield 2015 -
PER 2014 49,72
PER 2015 36,12
EV / Sales 2014 14,3x
EV / Sales 2015 11,3x
Capitalization 33 223 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
4d ago ALEXION PHARMACEUTICALS : Assigned Patent
6d ago Wall St. rallies, S&P back above 14-day moving average
09/20 ALEXION PHARMACEUTICALS : Asfotase Alfa Secures Orphan Drug Designation in Japan
09/20 ALEXION PHARMACEUTICALS : NICE Suggests Commissioning of Eculizumab for Patients..
09/17 ALEXION PHARMACEUTICALS : Asfotase Alfa Granted Orphan Drug Designation in Japan
09/17 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
09/17 ALEXION PHARMACEUTICALS : Strengthens and Broadens Its Executive Leadership Team
09/16 Roche's $8 billion InterMune buy not a signal for more big deals
09/14 ALEXION PHARMACEUTICALS : Improved Survival Observed in Pediatric Patients with ..
09/11 ALEXION PHARMACEUTICALS : Asfotase Alfa Gets Orphan Drug Designation in Japan
09/10 ALEXION PHARMACEUTICALS : NICE Suggests Commissioning of Eculizumab for Patients..
09/08 ALEXION PHARMACEUTICALS : Asfotase Alfa Granted Orphan Drug Designation in Japan
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF